Bioinformatics and Systems Medicine Laboratory
General information | Expression | Regulation | Mutation | Interaction

Basic Information

Gene ID

1869

Name

E2F1

Synonymous

E2F-1|RBAP1|RBBP3|RBP3;E2F transcription factor 1;E2F1;E2F transcription factor 1

Definition

PBR3|PRB-binding protein E2F-1|RBAP-1|RBBP-3|retinoblastoma-associated protein 1|retinoblastoma-binding protein 3|transcription factor E2F1

Position

20q11.2

Gene Type

protein-coding

Gene Regulation:

Transcription Factors
Post Transcriptional Modification From dbPTM
Methylation Profile From DiseaseMeth database

Transcription Factors

   | Top |

Regulation From TransFac database

E2F-1(h) --> CCND1(h) (DNA binding).
E2F-1(h) --> cycE(h) (DNA binding).
E2F-1(h) --> E2F1(h) (DNA binding).
E2F-1(h) --> B-myb(m) (DNA binding).
E2F-1(h) --> H2A.1(h) (DNA binding).
E2F-1(h) + ATP --cyclinA(h):Cdk2(h)--> E2F-1(h){p} + ADP (phosphorylation)
E2F-1(h) + pRb(h) <==> E2F-1(h):pRb(h) (binding)
E2F-1(h) + ATP --cyclinE(h):Cdk2(h)--> E2F-1(h){p} + ADP (phosphorylation)
E2F-1(h) + DP-1(h) + pRb(h) <==> E2F-1(h):DP-1(h):pRb(h) (binding)
E2F-1(h) + DP-2(h) + pRb(h) <==> E2F-1(h):DP-2(h):pRb(h) (binding)
E2F-1(h) + DP-1(h) <==> E2F-1(h):DP-1(h) (binding)
E2F-1(h) + p53(h) <==> E2F-1(h):p53(h) (binding)
Mdm4-L(m) + E2F-1(h) <==> Mdm4-L(m):E2F-1(h) (binding)
TBP(h) + E2F-1(h) <==> TBP(h):E2F-1(h) (binding).
E2F-2(h) + E2F-1(h) <==> E2F-2(h):E2F-1(h) (binding).
E2F-1(h) + DP-1(m) <==> E2F-1(h):DP-1(m) (binding).
DP-2(h) + E2F-1(h) <==> E2F-1(h):DP-2(h) (binding)
DDB(h) + E2F-1(h) <==> DDB(h):E2F-1(h) (binding).
E2F-1(h) + E2F-1(h) <==> E2F-1(h):E2F-1(h) (binding).
p300(h) + p130(h) + E2F-1(h) <==> p300(h):p130(h):E2F-1(h) (binding)
E2F-1(h) --> RB1(h) (DNA binding).
E2F-1(h) + carm1(h) <==> E2F-1(h):carm1(h) (binding)
E2F-1(h) + ATP --> E2F-1(h){p} + ADP (phosphorylation)
E2F-1(h) --> cyclinD1(h) (increase of abundance)
E2F-1(h) --> TK1(h) (increase of abundance)
E2F-1(h) --> pRb(h) (increase of abundance)
E2F-1(h) + IKK-alpha(h) <==> E2F-1(h):IKK-alpha(h) (binding)
BRD2(m.s.) + E2F-1(h) <==> BRD2(m.s.):E2F-1(h) (binding)
E2F-1(h) + acetyl-CoA --> E2F-1(h){aceK} + CoA (acetylation)
E2F-1(h) + pRb(h) <==> E2F-1(h):pRb(h) (binding)
p/CAF(h) + E2F-1(h) <==> p/CAF(h):E2F-1(h) (binding)
E2F-1(h) --> BCL2(h) (DNA binding; transactivation).
E2F-1(h) --/ TERT(h) (DNA binding; transrepression).
TOP2BP1(h) + E2F-1(h) <==> TOP2BP1(h):E2F-1(h) (binding)
HDAC1(h) + E2F-1(h) + pRb(h) + Dnmt1(h) <==> HDAC1(h):E2F-1(h):pRb(h):Dnmt1(h) (binding)
E2F-1(h) --> TNFSF11(h) (DNA binding).
E2F-1(h) --/ DIRAS3(h) (DNA binding; transrepression).
E2F-1(h) --> GADD45B(h) (DNA binding).
E2F-1(h) --> Nox4(m) (DNA binding).
pawr(h) + E2F-1(h) <==> pawr(h):E2F-1(h) (binding)
pawr(h) + E2F-1(h) <==> pawr(h):E2F-1(h) (binding)
E2F-1(h) + TFIIH-p62(h) <==> E2F-1(h):TFIIH-p62(h) (binding)
E2F-1(h) + TFIIH-p90(h):TFIIH-p62(h):MO15(h) <==> E2F-1(h):TFIIH-p90(h):TFIIH-p62(h):MO15(h) (binding)
E2F-1(h) + trrap(h) <==> E2F-1(h):trrap(h) (binding)
E2F-1(h) + RelA-p65(h) <==> E2F-1(h):RelA-p65(h) (binding)
E2F-1(h) --> DBF4(h) (DNA binding).
E2F-1(h) --> RRP1B(h) (transactivation)
E2F-1(h) --> CASP7(h) (transactivation)
E2F-1(h) --> tk1(h) (transactivation)
rrp1b(h) + E2F-1(h) <==> rrp1b(h):E2F-1(h) (binding)
E2F-1(h) --> AURKB(h) (DNA binding).
E2F-1(h) --> BIK(h) (DNA binding).
E2F1(h) --> E2F-1(h) (expression).
IKK-alpha(h) --> E2F-1(h) (increase of abundance)
pRb(m.s.) --> E2F-1(h) (increase of abundance)
p75NTR(m.s.) --/ E2F-1(h) (decrease of abundance)
IL-2(m.s.) --> E2F-1(h) (increase of abundance)
atad2(h) --> E2F-1(h) (increase of abundance)
E2F-7(h) --/ E2F-1(h) (decrease of abundance)
E2F-8(h) --/ E2F-1(h) (decrease of abundance)
EGF(m.s.) --> E2F-1(h) (increase of abundance)
E2F-1(h) --> RB1(h) (DNA binding).
E2F-1(h) --> tk(HSV1) (DNA binding).
E2F-1(h) --> Pola1(m) (DNA binding).
E2F-1(h) --> cdc25A(h) (DNA binding).
E2F-1(h) --> CYC1(h) (DNA binding).
E2F-1(h) --> SIVA(m) (DNA binding; transactivation).
Sp1(m) + E2F-1(h) <==> Sp1(m):E2F-1(h) (binding)
Sp1(h) + E2F-1(h) <==> Sp1(h):E2F-1(h) (binding)
Sp1(m.s.) + E2F-1(h) <==> Sp1(m.s.):E2F-1(h) (binding)
brca1(h) + E2F-1(h) <==> brca1(h):E2F-1(h) (binding)
JAB1(h) + E2F-1(h) <==> JAB1(h):E2F-1(h) (binding)
MCRS1(h) + E2F-1(h) <==> MCRS1(h):E2F-1(h) (binding)
FHOS(h) + E2F-1(h) <==> FHOS(h):E2F-1(h) (binding)
Filamin(h) + E2F-1(h) <==> Filamin(h):E2F-1(h) (binding)
EIF1(h) + E2F-1(h) <==> EIF1(h):E2F-1(h) (binding)
fabp4(h) + E2F-1(h) <==> fabp4(h):E2F-1(h) (binding)
MX1(h) + E2F-1(h) <==> MX1(h):E2F-1(h) (binding)
HRMT1L3(h) + E2F-1(h) <==> HRMT1L3(h):E2F-1(h) (binding)
E2F-1(h) + RING1B(h) <==> E2F-1(h):RING1B(h) (binding)
RanBPM(h) + E2F-1(h) <==> RanBPM(h):E2F-1(h) (binding)
JAB1(h) + E2F-1(h) <==> JAB1(h):E2F-1(h) (binding)
E2F-1(h) --> p53(r) (increase of abundance)
E2F-1(h) --> Cdkn2a(r) (transactivation)
E2F-1(h) --> Pcna(r) (transactivation)
E2F-1(h) --> PCNA(r) (increase of abundance)
E2F-1(h) + 2 ATP --GSK3beta(m.s.)--> E2F-1(h){pS403}{pT433} + 2 ADP (phosphorylation)
p53-isoform1(h) + E2F-1(h) <==> p53-isoform1(h):E2F-1(h) (binding)
E2F-1(h) + p53-isoform1(h){pS315} <==> E2F-1(h):p53-isoform1(h){pS315} (binding)
Slim-3(h) + E2F-1(h) <==> Slim-3(h):E2F-1(h) (binding)
p/CAF(m.s.) + E2F-1(h) <==> p/CAF(m.s.):E2F-1(h) (binding)
E2F-1(h) + DEDAF(h) <==> E2F-1(h):DEDAF(h) (binding)
E2F-1(h) + 3 acetyl-CoA --> E2F-1(h){aceK117}{aceK120}{aceK125} + 3 CoA (acetylation)
E2F-1(h) + p300(m.s.) <==> E2F-1(h):p300(m.s.) (binding)
E2F-1(h) + acetyl-CoA --CBP(m.s.)--> E2F-1(h){ace} + CoA (acetylation)
E2F-1(h) + acetyl-CoA --p300(m.s.)--> E2F-1(h){ace} + CoA (acetylation)
E2F-1(h) + acetyl-CoA --GCN5(m.s.)--> E2F-1(h){ace} + CoA (acetylation)
E2F-1(h) + 3 acetyl-CoA --p/CAF(h)--> E2F-1(h){aceK117}{aceK120}{aceK125} + 3 CoA (acetylation)
E2F-1(h) + p/CAF(h) <==> E2F-1(h):p/CAF(h) (binding)
E2F-1(h) --/ DIRAS3(h) (transrepression)
E2F-1(h) --> DUSP4(h) (transactivation)
E2F-1(h) --> CDKN2A(h) (transactivation)
E2F-1(h) --> PCSK6(h) (transactivation)
E2F-1(h) --> PTPRO(h) (DNA binding; transactivation).
E2F-1(h) --> MIRN17(h) (DNA binding; transactivation).
E2F-1(h) + ATP --ATM(m.s.)--> E2F-1(h){pS31} + ADP (phosphorylation)
E2F-1(h) + ATP --ATR(m.s.)--> E2F-1(h){pS31} + ADP (phosphorylation)
E2F-1(h) --> E2F-6(h) (transactivation)
E2F-1(h) --> E2F-6(m) (transactivation)
E2F-1(h) + 3 ATP --> E2F-1(h){pS403}{pY411}{pT433} + 3 ADP (phosphorylation)
E2F-1(h) + 3 ATP --TFIIH-p62(h)--> E2F-1(h){pS403}{pY411}{pT433} + 3 ADP (phosphorylation)
E2F-1(h) + MO15(h) <==> E2F-1(h):MO15(h) (binding)
E2F-1(h) --> MAP3K5(h) (DNA binding; transactivation).
E2F-1(h) --> MAP3K5(h) (transactivation)
E2F-1(h) --> ASK1(h) (increase of abundance)
E2F-1(h) --> ASK1(h){p} (increase of phosphorylation)
rrp1b(rb) + E2F-1(h) <==> rrp1b(rb):E2F-1(h) (binding)
E2F-1(h) + rrp1b-isoform1(h) <==> E2F-1(h):rrp1b-isoform1(h) (binding)
E2F1(h) --> E2F-1(h) (expression).
E2F1(h) --> E2F1(h) (expression).
hsa-miR-106a --/ E2F1(h) (predicted)
hsa-miR-106b --/ E2F1(h) (predicted)
hsa-miR-17-5p --/ E2F1(h) (translational repression)
hsa-miR-20a --/ E2F1(h) (predicted)
hsa-miR-20a --/ E2F1(h) (translational repression)
hsa-miR-20b --/ E2F1(h) (predicted)
hsa-miR-330 --/ E2F1(h) (translational repression).

Post Transcriptional Modification From dbPTM

   | Top |

Location (AA)

PTM type

Literature

Database

375Phosphoserine.Swiss-Prot 53.0
403Phosphoserine (CDK7)10428966Phospho.ELM 6.0
433Phosphothreonine (CDK7)10428966Phospho.ELM 6.0
364Phosphoserine (CHK2)12717439Phospho.ELM 6.0
31Phosphoserine (ATM;ATR)11459832Phospho.ELM 6.0
332Phosphoserine (CDK1)8087847Phospho.ELM 6.0
337Phosphoserine (CDK1)8087847Phospho.ELM 6.0
375Phosphoserine17081983Phospho.ELM 6.0

Methylation Profile From DiseaseMeth database

   | Top |

Chromosome

Location

Source

chr20

Promoter: 31737354 - 31739354Agilent_014791

chr20

Promoter: 31737354 - 31739354GSE27584

chr20

Promoter: 31737354 - 31739354Agilent_014791_44K

chr20

Promoter: 31737354 - 31739354Agilent_014791


Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston Rights Reserved
Site Policies | State of Texas